Gagandeep Singh Bedi has resigned as managing director, according to a statement released by AstraZeneca Pharma India on Wednesday.
The pharmaceutical company announced that Sanjeev Panchal has been appointed as managing director for a three-year term beginning January 1, 2023.
According to the statement, Panchal began working for AstraZeneca Pharma in February 2003 as a brand associate and advanced through a number of positions in Singapore and the United Kingdom (UK), India, Indonesia, and the Asia Pacific area.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
